Ignite Creation Date:
2024-05-06 @ 4:05 PM
Last Modification Date:
2024-10-26 @ 2:03 PM
Study NCT ID:
NCT04861792
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2021-04-21
Brief Title:
Michigan SPARC Trial
Sponsor:
Kaiser Permanente
Organization:
Kaiser Permanente
Study Overview
Official Title:
The Michigan Sustained Patient-centered Alcohol-Related Care MI-SPARC Trial
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MI-SPARC
Brief Summary:
Unhealthy alcohol use is a major contributor to morbidity and mortality in the US Although effective prevention for unhealthy alcohol use and medication treatment for alcohol use disorders AUDs can be provided in primary care PC they have historically not been included in routine services As a result most patients do not receive evidence-based prevention or treatment for unhealthy alcohol use Several efforts have successfully implemented alcohol-related preventive care-referred to as screening and brief intervention SBI but efforts to increase treatment of AUDs with medications have been less successful Moreover implementation efforts have usually neglected smaller PC practices in which most PC is provided
The Michigan SPARC trial is a partnership between Kaiser Permanente Washington Health Research Institute KPWHRI in Seattle bringing extensive expertise implementing evidence-based alcohol-related care and Altarum Institute in Ann Arbor Michigan bringing demonstrated success engaging over 500 small to medium Michigan-based PC practices in effective quality improvement QI efforts The project builds on Altarums innovative approach to implementing new or improved clinical care using practice facilitators to provide continuing medical education and maintenance of certification CMEMOC programs to PC providers along with ongoing support for QI using evidence-based implementation strategies The KPWHRI team recently finished the highly successful AHRQ-funded Sustained Patient-centered Alcohol-Related Care SPARC trial using similar implementation strategies in KP Washington including use of electronic health records and performance monitoring and feedback and also developed a patient decision aid to support shared decision-making between patients with high-risk drinking andor AUDs and their PC providers
The Michigan SPARC trial combines Altarums expertise in QI in small-medium PC practices in Michigan with KPWHRIs expertise implementing evidence-based prevention and treatment of unhealthy alcohol use-specifically alcohol SBI and medication treatment for AUDs
Specific Aims of the Michigan SPARC trial had to be markedly modified due to the trial beginning in March 2020 at the same time as the COVID pandemic A trial was not possible The revised aims were to describe alcohol screening brief intervention AUD diagnosis and initiation of medication treatment for AUD before and after the Michigan SPARC model was implemented in small to medium PC practices in Michigan
The Michigan SPARC trial is a partnership between Kaiser Permanente Washington Health Research Institute KPWHRI in Seattle bringing extensive expertise implementing evidence-based alcohol-related care and Altarum Institute in Ann Arbor Michigan bringing demonstrated success engaging over 500 small to medium Michigan-based PC practices in effective quality improvement QI efforts The project builds on Altarums innovative approach to implementing new or improved clinical care using practice facilitators to provide continuing medical education and maintenance of certification CMEMOC programs to PC providers along with ongoing support for QI using evidence-based implementation strategies The KPWHRI team recently finished the highly successful AHRQ-funded Sustained Patient-centered Alcohol-Related Care SPARC trial using similar implementation strategies in KP Washington including use of electronic health records and performance monitoring and feedback and also developed a patient decision aid to support shared decision-making between patients with high-risk drinking andor AUDs and their PC providers
The Michigan SPARC trial combines Altarums expertise in QI in small-medium PC practices in Michigan with KPWHRIs expertise implementing evidence-based prevention and treatment of unhealthy alcohol use-specifically alcohol SBI and medication treatment for AUDs
Specific Aims of the Michigan SPARC trial had to be markedly modified due to the trial beginning in March 2020 at the same time as the COVID pandemic A trial was not possible The revised aims were to describe alcohol screening brief intervention AUD diagnosis and initiation of medication treatment for AUD before and after the Michigan SPARC model was implemented in small to medium PC practices in Michigan
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None